Lifestyle as well as metabolic syndrome and non-alcoholic fatty liver disease: an umbrella review of evidence from observational studies and randomized controlled trials
Obesity is not simply a willpower problem
Human GLP-1 based GLP-1RA includes liraglutide, albiglutide, dulaglutide, efpeglenatide, and semaglutide
The development of novel drug delivery systems or formulations is also essential to improve patient compliance and reduce gastrointestinal adverse effects
These medicines work by mimicking the action of a naturally occurring hormone called GLP-1, which is released from the intestine in response to food intake
Exposing transdermal patches to external heat sources (heating pads, saunas, hot tubs, prolonged sun exposure) can significantly increase drug absorption and potentially cause overdose